Sitagliptin (Januvia) PDF

Preview

Summary

adult 1 ati assignments...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Katelyn Mehalic STUDENT NAME _____________________________________ Sitagliptin (Januvia) DPP-4 inhibitor CATEGORY CLASS ______________________________________________________________________

MEDICATION __________________________________________________________________________

REVIEW MODULE CHAPTER ___________

PURPOSE OF MEDICATION

Expected Pharmacological Action Inhibits the dipeptidyl peptidase-4 enzyme to slow inactivation of incretin hormones

Therapeutic Use To achieve control of glucose levels in type 2 diabetes as monotherapy or with metformin or other thiazolidinediones

Complications Headache, acute pancreatitis, N/V/D, abdominal pain, constipation, acute renal failure, worsening renal function, stevens-johnson syndrome, rash, urticaria, cutaneous vasculitis, angioedema, anaphylaxis

Medication Administration PO

Contraindications/Precautions Hypersensitivity to sitagliptin Nursing Interventions

Interactions Digoxin, Beta Blockers, ACE inhibitors, disopyramide, fluoxetine, insulin, or insulin secreatagogue such as sulfonylureas

monitor blood glucose levels, assess renal fxn before treatment and during treatment, monitor for hypersensitivity rxn, monitor for s/s for HF and if presents report immediately

Client Education Evaluation of Medication Effectiveness Patient will have controlled blood glucose levels and no renal damage present.

ACTIVE LEARNING TEMPLATES

Diet controled program and exercise program, do not crew, crush or split tablet, notify doctor if adverse effects occur, educate pt. on how to monitor blood glucose levels.

THERAPEUTIC PROCEDURE

A7...